| |
 |
|
A conversation with Robert Irene, Armada Health
Part GPO, part pharmacy and patient services company, Armada Health Care works both with specialty manufacturers to streamline the distribution of their high-touch products
|
|
Solving the payer's problem: a new key to market access
Understand when total cost of care is the only winning argument - and when you can ignore it, says Oliver Wyman
|
|
Express Scripts and Walgreens settle, but now 'narrow networks' are in play
Implications for pharma are in continuing pricing pressure, and preferences for distribution channels
|
|
Owens & Minor plans to acquire Movianto Group, a European healthcare 3PL
Action adds to the increasing number of global healthcare-distribution pathways
|
|
Coordinating payer contracts and direct-to-patient discounting
Although controversial, patient-focused discounts can play a valuable role in managed-markets programs
|
|
Insurers are raising their expectations of the value of new therapies, says PwC
While 78% of survey respondents will "demand clear proof of cost savings" to ensure formulary placement, 44% of them have "little or no confidence" in the economic arguments presented by pharmacos
|
|
Maintain your integrity: manufacturers and the 340B integrity provision
It has been more than two years since the passage of the Affordable Care Act, and pharmaceutical manufacturers have faced some difficult challenges.
|
 |
|
A Conversation with Cynthia LaConte, Dohmen Company
Dohmen pioneers an integrated, 'conflict free' pharmaceutical services company
|
|
A conversation with Jeffrey Berkowitz, Walgreens
The leading chain pharmacy steps up its role as healthcare provider and partner to pharma
|
|
2012 site selection report
Biopharma remains a bright spot in US and international economic activity, even while the overall outlook remains cloudy
|
|
|
|
|
